Single-Dose Bioequivalence Study Comparing Two 2 mg Nicotine Lozenges

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 19, 2018

Primary Completion Date

March 27, 2018

Study Completion Date

March 27, 2018

Conditions

Smoking Cessation

Interventions

DRUG

Nicotine lozenge

Nicotine mint lozenge, 2 mg

DRUG

Nicotine lozenge

NiQuitin mint lozenge, 2 mg

Trial Locations (1)

Bloemfontein Early Phase Clinical Unit, PAREXEL International (South Africa), Bloemfontein